Cargando…
Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan through Hsp70
Hypertensive nephrosclerosis is the second most common cause of end-stage renal disease after diabetes. For years, hypertensive kidney disease has been focused on the afferent arterioles and glomeruli damage and the involvement of the renin angiotensin system (RAS). Nonetheless, in recent years, nov...
Autores principales: | Costantino, Valeria Victoria, Gil Lorenzo, Andrea Fernanda, Bocanegra, Victoria, Vallés, Patricia G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619557/ https://www.ncbi.nlm.nih.gov/pubmed/34831368 http://dx.doi.org/10.3390/cells10113146 |
Ejemplares similares
-
Prednisolone Co-Administered with Losartan Confers Renoprotection in Patients with IgA Nephropathy
por: Horita, Yoshio, et al.
Publicado: (2007) -
Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy
por: Bae, Eunjin, et al.
Publicado: (2022) -
Acute kidney injury: what part do toll-like receptors play?
por: Vallés, Patricia G, et al.
Publicado: (2014) -
Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
por: Maquigussa, Edgar, et al.
Publicado: (2018) -
HSP70 and Primary Arterial Hypertension
por: Rodriguez-Iturbe, Bernardo, et al.
Publicado: (2023)